Back
SPDR S&P® North American Natural Res ETF Vs. Astrana Health Industry Stock Comparison
Sell
20
NANR
SPDR S&P® North American Natural Res ETF
Last Price:
55.95
Seasonality Move:
4.03%
Sell
11
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
Sell
20
SPDR S&P® North American Natural Res ETF (NANR)
is a Sell
Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?
- The current SPDR S&P® North American Natural Res ETF [NANR] share price is $56.08. The Score for NANR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NANR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
11
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $42.9300. The Score for ASTH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NANR Stock Price Chart
What is SPDR S&P® North American Natural Res ETF's stock price today?
-
The SPDR S&P® North American Natural Res ETF share price today is $56.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NANR is experiencing selling pressure, which indicates risk of future bearish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $42.9300
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing selling pressure, which indicates risk of future bearish movement.
NANR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 44.25 | Sell |
| Chaikin Money Flow: | -11055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.23 - 57.65) | Sell |
| Bollinger Bands (100): | (54.27 - 57.15) | Buy |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.01 | Sell |
| Relative Strength Index (14 RSI): | 27.01 | Sell |
| Chaikin Money Flow: | -465704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.464 - 60.504) | Sell |
| Bollinger Bands (100): | (44.6431 - 56.9831) | Sell |
NANR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.74 | Sell |
| 20-day SMA: | 56.82 | Sell |
| 50-day SMA: | 56.32 | Sell |
| 200-day SMA: | 54.58 | Buy |
| 8-day EMA: | 56.75 | Sell |
| 20-day EMA: | 56.77 | Sell |
| 50-day EMA: | 56.46 | Sell |
| 200-day EMA: | 54.91 | Buy |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.51 | Sell |
| 20-day SMA: | 55.48 | Sell |
| 50-day SMA: | 55.12 | Sell |
| 200-day SMA: | 45.28 | Sell |
| 8-day EMA: | 50.74 | Sell |
| 20-day EMA: | 53.85 | Sell |
| 50-day EMA: | 53.99 | Sell |
| 200-day EMA: | 46.89 | Sell |
SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
SPDR S&P® North American Natural Res ETF Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||